{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:03:53Z","timestamp":1779840233496,"version":"3.53.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12389-x","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:05:48Z","timestamp":1776341148000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterising the urinary metabolome in HIV\/TB coinfection and the impact of antiretroviral treatment"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-129X","authenticated-orcid":false,"given":"Bianca","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4276-7117","authenticated-orcid":false,"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4920-4090","authenticated-orcid":false,"given":"Laneke","family":"Luies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"12389_CR1","unstructured":"HIV\/AIDS JUNPo. AIDS, crisis and power to transform (Text extract): UNAIDS global AIDS update 2025 (Executive Summary). Infect Dis Immun. 2024;10.1097."},{"key":"12389_CR2","unstructured":"Global tuberculosis report 2024. Press release. 2024]. Geneva, Switzerland (WHO Press): World Health Organization."},{"issue":"4","key":"12389_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2174\/2213235X113016660006","volume":"1","author":"L De Villiers","year":"2013","unstructured":"De Villiers L, Loots DT. Using metabolomics for elucidating the mechanisms related to tuberculosis treatment failure. Curr Metabolomics. 2013;1(4):306\u201317.","journal-title":"Curr Metabolomics"},{"issue":"1","key":"12389_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s42399-023-01568-z","volume":"5","author":"C Olivier","year":"2023","unstructured":"Olivier C, Luies L. Who goals and beyond: managing HIV\/TB Co-infection in South Africa. SN Compr Clin Med. 2023;5(1):251.","journal-title":"SN Compr Clin Med"},{"key":"12389_CR5","unstructured":"World Health Organization. Global tuberculosis report 2023. World Health Organization. 2023."},{"key":"12389_CR6","unstructured":"Organization WH. Who operational handbook on tuberculosis. Module, 6: tuberculosis and comorbidities: World Health Organization; 2024."},{"key":"12389_CR7","unstructured":"WHO. Guidelines approved by the Guidelines review committee. Geneva, Switzerland: Geneva, Switzerland (WHO Press): World Health Organization; 2021 press release."},{"issue":"2","key":"12389_CR8","doi-asserted-by":"publisher","first-page":"e1002464","DOI":"10.1371\/journal.ppat.1002464","volume":"8","author":"A Pawlowski","year":"2012","unstructured":"Pawlowski A, Jansson M, Sk\u00f6ld M, Rottenberg ME, K\u00e4llenius G. Tuberculosis and HIV co-infection. PLoS Pathog. 2012;8(2):e1002464\u2013e.","journal-title":"PLoS Pathog"},{"key":"12389_CR9","doi-asserted-by":"crossref","unstructured":"Liebenberg C, Luies L, Williams AA. Metabolomics as a tool to investigate HIV\/TB Co-infection. Front Mol Biosci. 2021;8.","DOI":"10.3389\/fmolb.2021.692823"},{"issue":"1","key":"12389_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1186\/s12879-023-08505-4","volume":"23","author":"C Herbert","year":"2023","unstructured":"Herbert C, Luies L, Loots DT, Williams AA. The metabolic consequences of HIV\/TB co-infection. BMC Infect Dis. 2023;23(1):536.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"12389_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11306-024-02148-5","volume":"20","author":"C Olivier","year":"2024","unstructured":"Olivier C, Luies L. Metabolic insights into HIV\/TB co-infection: an untargeted urinary metabolomics approach. Metabolomics. 2024;20(4):78.","journal-title":"Metabolomics"},{"issue":"5","key":"12389_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s11306-024-02161-8","volume":"20","author":"C Pretorius","year":"2024","unstructured":"Pretorius C, Luies L. Characterising the urinary acylcarnitine and amino acid profiles of HIV\/TB co-infection, using LC-MS metabolomics. Metabolomics. 2024;20(5):92.","journal-title":"Metabolomics"},{"issue":"2","key":"12389_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/jod.jod_21_18","volume":"10","author":"SKS Masuku","year":"2019","unstructured":"Masuku SKS, Tsoka-Gwegweni J, Sartorius B. HIV and Antiretroviral therapy-induced metabolic syndrome in people living with HIV and its implications for Care: a critical review. J Diabetology. 2019;10(2):41\u201347.","journal-title":"J Diabetology"},{"issue":"4","key":"12389_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"12389_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12916-016-0603-9","volume":"14","author":"A Gupta-Wright","year":"2016","unstructured":"Gupta-Wright A, Peters JA, Flach C, Lawn SD. Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-saharan Africa: a systematic review and meta-analysis. BMC Med. 2016;14(1):53.","journal-title":"BMC Med"},{"key":"12389_CR16","unstructured":"Clinical and Laboratory Standards Institute. CLSI guideline PRE05. Processes for the collection of urine specimens 2024. https:\/\/clsi.org\/shop\/standards\/pre05\/ [1st ed: [10]. Available from."},{"issue":"4","key":"12389_CR17","doi-asserted-by":"publisher","first-page":"103449","DOI":"10.1016\/j.xpro.2024.103449","volume":"5","author":"B Allen","year":"2024","unstructured":"Allen B, Luies L. Protocol for a low-volume, direct analysis urine preparation procedure for non-targeted GC-MS metabolomics. Star Protocol. 2024;5(4):103449.","journal-title":"Star Protocol"},{"issue":"1","key":"12389_CR18","doi-asserted-by":"publisher","first-page":"17591","DOI":"10.1038\/s41598-023-44690-7","volume":"13","author":"C Olivier","year":"2023","unstructured":"Olivier C, Allen B, Luies L. Optimising a urinary extraction method for non-targeted GC-MS metabolomics. Sci Rep. 2023;13(1):17591.","journal-title":"Sci Rep"},{"issue":"8","key":"12389_CR19","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1258\/095646206778145659","volume":"17","author":"K Manavi","year":"2006","unstructured":"Manavi K, Scott G. Comparison of time to undetectable HIV viral load in the first 16 weeks after the start of three and four antiretroviral regimens. Int J STD AIDS. 2006;17(8):522\u201324.","journal-title":"Int J STD AIDS"},{"key":"12389_CR20","unstructured":"Care IAoPoA. Viral load 2021 [Available from: https:\/\/www.iapac.org\/fact-sheet\/viral-load\/."},{"issue":"1","key":"12389_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"V den Berg Ra","year":"2006","unstructured":"den Berg Ra V, Hoefsloot HCJ, Westerhuis JA, Smilde AK, der Werf Mj V. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics. 2006;7(1):142.","journal-title":"BMC Genomics"},{"issue":"1","key":"12389_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc: Ser B (methodological). 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc: Ser B (methodological)"},{"key":"12389_CR23","doi-asserted-by":"crossref","unstructured":"Bongaerts M, Bonte R, Demirdas S, Jacobs EH, Oussoren E, van der Ploeg AT, et al. Using out-of-batch reference populations to improve untargeted metabolomics for screening inborn errors of metabolism. Metabolites. 2020;11(1).","DOI":"10.3390\/metabo11010008"},{"key":"12389_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s11306-007-0070-6","volume":"3","author":"O Fiehn","year":"2007","unstructured":"Fiehn O, Robertson D, Griffin J, van der Werf M, Nikolau B, Morrison N, et al. The metabolomics standards initiative (MSI). Metabolomics. 2007;3:175\u201378.","journal-title":"Metabolomics"},{"key":"12389_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11306-013-0598-6","volume":"10","author":"E Saccenti","year":"2014","unstructured":"Saccenti E, Hoefsloot HC, Smilde AK, Westerhuis JA, Hendriks MM. Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics. 2014;10:361\u201374.","journal-title":"Metabolomics"},{"issue":"11","key":"12389_CR26","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2217\/bmm-2017-0141","volume":"11","author":"L Luies","year":"2017","unstructured":"Luies L, du Preez I, Loots DT. The role of metabolomics in tuberculosis treatment research. Biomark Med. 2017;11(11):1017\u201329.","journal-title":"Biomark Med"},{"key":"12389_CR27","doi-asserted-by":"crossref","unstructured":"Olivier C, Luies L. Metabolic insights into HIV\/TB co-infection: an untargeted urinary metabolomics approach. Metabolomics. 2024;20(78).","DOI":"10.1007\/s11306-024-02148-5"},{"issue":"D1","key":"12389_CR28","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, et al. HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res. 2022;50(D1):D622\u2013d31.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"12389_CR29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11306-017-1261-4","volume":"13","author":"L Luies","year":"2017","unstructured":"Luies L, Mienie J, Motshwane C, Ronacher K, Walzl G, Loots DT. Urinary metabolite markers characterizing tuberculosis treatment failure. Metabolomics. 2017;13(10):124.","journal-title":"Metabolomics"},{"key":"12389_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/jssc.201200768","volume":"36","author":"M Hardt-Stremayr","year":"2013","unstructured":"Hardt-Stremayr M, Serena M, Greilberger J, Stiegler P, Matzi V, Schmid M, et al. Determination of metabolites of 5-hydroxymethylfurfural in human urine after oral application. J Separation Sci. 2013;36:670\u201376.","journal-title":"J Separation Sci"},{"key":"12389_CR31","doi-asserted-by":"crossref","unstructured":"Belloso WH, de Paz Sierra M, Navarro M, Sanchez ML, Perelsztein AG, Musso CG. Impaired urine dilution capability in HIV stable patients. Int J Nephrol. 2014, 2014;381985.","DOI":"10.1155\/2014\/381985"},{"issue":"1","key":"12389_CR32","doi-asserted-by":"publisher","first-page":"e0070821","DOI":"10.1128\/Spectrum.00708-21","volume":"9","author":"A Ishizaka","year":"2021","unstructured":"Ishizaka A, Koga M, Mizutani T, Parbie PK, Prawisuda D, Yusa N, et al. Unique gut microbiome in HIV patients on Antiretroviral therapy (art) suggests association with chronic inflammation. Microbiol Spectr. 2021;9(1):e0070821.","journal-title":"Microbiol Spectr"},{"key":"12389_CR33","doi-asserted-by":"publisher","first-page":"117445","DOI":"10.1016\/j.cca.2023.117445","volume":"547","author":"B Yalameha","year":"2023","unstructured":"Yalameha B, Nejabati HR. Urinary exosomal metabolites: overlooked clue for predicting cardiovascular risk. Clinica (rome) Acta. 2023;547:117445.","journal-title":"Clinica (rome) Acta"},{"issue":"6","key":"12389_CR34","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1021\/acsinfecdis.1c00162","volume":"7","author":"M Opperman","year":"2021","unstructured":"Opperman M, Loots DT, van Reenen M, Ronacher K, Walzl G, du Preez I. Chronological metabolic response to intensive phase TB therapy in patients with cured and failed treatment outcomes. ACS Infect Dis. 2021;7(6):1859\u201369.","journal-title":"ACS Infect Dis"},{"key":"12389_CR35","doi-asserted-by":"publisher","first-page":"711746","DOI":"10.3389\/fcimb.2021.711746","volume":"11","author":"H Xu","year":"2021","unstructured":"Xu H, Tamrat NE, Gao J, Xu J, Zhou Y, Zhang S, et al. Combined signature of the urinary microbiome and metabolome in patients with interstitial cystitis. Front Cell Infect Microbiol. 2021;11:711746.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"12389_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/toxsci\/kfaa072","volume":"176","author":"Y Rong","year":"2020","unstructured":"Rong Y, Kiang TKL. Characterizations of human UDP-Glucuronosyltransferase enzymes in the conjugation of p-cresol. Toxicological Sci. 2020;176(2):285\u201396.","journal-title":"Toxicological Sci"},{"issue":"3","key":"12389_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11306-016-0979-8","volume":"12","author":"L Luies","year":"2016","unstructured":"Luies L, Loots DT. Tuberculosis metabolomics reveals adaptations of man and microbe in order to outcompete and survive. Metabolomics. 2016;12(3):1\u20139.","journal-title":"Metabolomics"},{"key":"12389_CR38","doi-asserted-by":"crossref","unstructured":"Deme P, Rubin LH, Yu D, Xu Y, Nakigozi G, Nakasujja N, et al. Immunometabolic reprogramming in response to HIV infection is not fully normalized by suppressive Antiretroviral therapy. Viruses. 2022;14(6).","DOI":"10.3390\/v14061313"},{"key":"12389_CR39","doi-asserted-by":"crossref","unstructured":"Luies L, du Preez I. The echo of pulmonary tuberculosis: mechanisms of Clinical symptoms and Other disease-induced systemic complications. Clin Microbiol Rev. 2020;33(4).","DOI":"10.1128\/CMR.00036-20"},{"key":"12389_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/B978-0-08-091283-7.00014-X","volume-title":"Comprehensive natural products chemistry","author":"PM Shoolinghin-Jordan","year":"1999","unstructured":"Shoolinghin-Jordan PM, Campuzano IDG. 1.14 - biosynthesis of 6-methylsalicylic acid. In: Barton S, Nakanishi K, Meth-Cohn O, editors. Comprehensive natural products chemistry. Oxford: Pergamon; 1999. p. 345\u201365."},{"issue":"23","key":"12389_CR41","doi-asserted-by":"publisher","first-page":"9283","DOI":"10.1073\/pnas.85.23.9283","volume":"85","author":"R Pal","year":"1988","unstructured":"Pal R, Gallo RC, Sarngadharan MG. Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of Monensin and Cerulenin. Proc Natl Acad Sci USA. 1988;85(23):9283\u201386.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9024","key":"12389_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(96)01034-3","volume":"348","author":"D Sharpstone","year":"1996","unstructured":"Sharpstone D, Gazzard B. Gastrointestinal manifestations of HIV infection. Lancet. 1996;348(9024):379\u201383.","journal-title":"Lancet"},{"issue":"1","key":"12389_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s42003-021-01926-4","volume":"4","author":"A Dwivedy","year":"2021","unstructured":"Dwivedy A, Ashraf A, Jha B, Kumar D, Agarwal N, Biswal BK. De Novo histidine biosynthesis protects Mycobacterium tuberculosis from host IFN-\u03b3 mediated histidine starvation. Commun Biol. 2021;4(1):410.","journal-title":"Commun Biol"},{"key":"12389_CR44","doi-asserted-by":"crossref","unstructured":"Jacyna J, Kordalewska M, Artymowicz M, Markuszewski M, Matuszewski M, Markuszewski MJ. Pre- and post-resection urine metabolic profiles of bladder cancer patients: results of preliminary studies on time series metabolomics analysis. Cancers (Basel). 2022;14(5).","DOI":"10.3390\/cancers14051210"},{"issue":"1","key":"12389_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0021-9150(99)00263-4","volume":"148","author":"M Inouye","year":"2000","unstructured":"Inouye M, Mio T, Sumino K. Dicarboxylic acids as markers of fatty acid peroxidation in diabetes. Atherosclerosis. 2000;148(1):197\u2013202.","journal-title":"Atherosclerosis"},{"issue":"20","key":"12389_CR46","doi-asserted-by":"publisher","first-page":"6147","DOI":"10.3390\/molecules26206147","volume":"26","author":"Y Sun","year":"2021","unstructured":"Sun Y, Tang H, Wang Y. Progress and challenges in quantifying carbonyl-metabolomic phenomes with LC-MS\/MS. Molecules. 2021;26(20):6147.","journal-title":"Molecules"},{"key":"12389_CR47","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/ejlt.200900245","volume":"112","author":"U Bornscheuer","year":"2010","unstructured":"Bornscheuer U, Hesseler M. Enzymatic removal of 3-monochloropropanediol (3-MCPD) and its esters from oils. Eur J Lipid Sci Technol. 2010;112:552\u201356.","journal-title":"Eur J Lipid Sci Technol"},{"key":"12389_CR48","unstructured":"Luies L. Characterising tuberculosis and treatment failure thereof using metabolomics. Potchefstroom Campus: North-West University; 2017."},{"issue":"7","key":"12389_CR49","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/vaccines12070730","volume":"12","author":"K Hosseinian","year":"2024","unstructured":"Hosseinian K, Gerami A, Bral M, Venketaraman V. Mycobacterium tuberculosis-human immunodeficiency virus infection and the role of T cells in protection. Vaccines. 2024;12(7):730.","journal-title":"Vaccines"},{"issue":"3","key":"12389_CR50","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0009-8981(77)90246-7","volume":"77","author":"JP Kamerling","year":"1977","unstructured":"Kamerling JP, Duran M, Bruinvis L, Ketting D, Wadman SK, de Groot CJ, et al. (2-Ethoxyethoxy)acetic acid: an unusual compound found in the gas chromatographic analysis of urinary organic acids. Clin Chim Acta. 1977;77(3):397\u2013405.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"12389_CR51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/03602532.2017.1293682","volume":"49","author":"G Yang","year":"2017","unstructured":"Yang G, Ge S, Singh R, Basu S, Shatzer K, Zen M, et al. Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metab Rev. 2017;49(2):105\u201338.","journal-title":"Drug Metab Rev"},{"issue":"4","key":"12389_CR52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/jes.2009.46","volume":"20","author":"MA Bergauff","year":"2010","unstructured":"Bergauff MA, Ward TJ, Noonan CW, Migliaccio CT, Simpson CD, Evanoski AR, et al. Urinary levoglucosan as a biomarker of wood smoke: results of human exposure studies. J Expo Sci Environ Epidemiol. 2010;20(4):385\u201392.","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"1","key":"12389_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1471-2458-8-255","volume":"8","author":"K Peltzer","year":"2008","unstructured":"Peltzer K, Nf-D P, Ramlagan S, Fomundam H. Use of traditional complementary and alternative medicine for HIV patients in KwaZulu-Natal, South Africa. BMC Public Health. 2008;8(1):255.","journal-title":"BMC Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12389-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12389-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:29:37Z","timestamp":1779838177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12389-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12389"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12389-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This investigation was conducted according to the Declaration of Helsinki and International Conference on Harmonisation Guidelines. Ethical approval for the larger study was obtained from the Research Ethics Committees of North-West University (reference no NWU-00355\u201320-A1) and the University of Cape Town (reference no 680\/2013). This sub-study was also ethically approved (reference no NWU-00355\u201320-A1-04). All participants gave written informed consent for participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (no participant identifiable information or images are present). All authors approve the final version to be submitted for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1040"}}